{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.6172","meta":{"versionId":"9","lastUpdated":"2020-12-23T01:03:07.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.6172","version":"20201223","name":"COVID19 SNOMED Value Set for Lymphadenopathy","status":"active","date":"2020-12-23T01:03:07-05:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"274741002","display":"Generalized enlarged lymph nodes (disorder)"},{"code":"274744005","display":"Localized enlarged lymph nodes (disorder)"},{"code":"30746006","display":"Lymphadenopathy (disorder)"},{"code":"49991000119104","display":"Focal lymphadenopathy (disorder)"},{"code":"870348009","display":"Regional lymphadenopathy caused by Bacillus of Calmette-Gu√©rin (disorder)"}]}]}}